Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Recruiting Not applicable

Appetite and Cognition Response to a Breakfast Cereal

NCT07782229 · tracked via the Priya Life Science USA tracker
Sponsor
General Mills
Phase
Not applicable
Started
2026-09-14
Last updated
2026-08-24

Condition(s) studied

Cognition

Investigational drug(s) / intervention(s)

Ready-To-Eat Cereal

Ready-To-Eat Cereal: Packaged Ready-To-Eat Cereal product available in retail stores

Study summary

The purpose of this study is to examine appetite and cognition responses following consumption of a ready-to-eat breakfast cereal.

Eligibility

Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Healthy adults 18-70 years * Habitual breakfast cereal consumers (at least several times per month) * Body mass index 18.5-29.9 kg/m2 (based on self-reported weight and height) * Understand and willing to follow the study procedures, including having access to a tablet or laptop to use the online platforms for appetite and cognition measurement * Willing to maintain habitual diet, physical activity pattern, and body weight throughout the trial * Willing to abstain from strenuous exercise, consuming alcoholic drinks 24 hours before the test day * Willing to provide informed consent to participate in the study Exclusion Criteria: * Age or body mass index outside of the inclusion criteria * Pregnant or lactating women, or women who are planning to become pregnant during the study * Known food allergies, sensitivities, or intolerance to any food or food ingredients * Participating in another clinical trial for food, investigational drug, nutritional supplement, or lifestyle modification * Taking medications that affect appetite, metabolism or blood pressure * Presence of acute diseases or infection * Presence or history of chronic diseases * Diagnosed with an eating disorder * Restraint eaters as determined by a score \>4 from the Dutch Eating Behavior Questionnaire1 * Lost or gained 5 or more pounds in the past 3-months * On a weight loss diet or undergoing intermittent fasting * COVID-19 infection within the past 3 months * Subjects who do not eat cereal products * Subjects who do not understand or are not willing to follow the study procedures

Primary outcome measure(s)

  • Rapid Visual Information Processing Task — 210 minutes
    This computer-based task requires participants to monitor a continuous stream of digits (1-9) presented one at a time on-screen and press the space bar when they detect three consecutive odd or three consecutive even digits. Both accuracy and reaction time will be evaluated.
  • Visual Analogue Scales for Appetite — 240 minutes
    This VAS questionnaire requires participants to score from 0-100 millimeters (mm) on 6 questions relating to: hunger, fullness, satiation, desire to eat, prospective consumption and satisfaction.

Trial sites (1)

FacilityCityRegionStatus
Remote Minneapolis Minnesota Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07782229 on ClinicalTrials.gov ↗ ← All trials in the USA